Skip to the main content.

Hope Bonnetti

Coding Conundrum: SPRAVATO® (Eskatamine), Part 2

Welcome back to Coding Conundrum: SPRAVATO® (Eskatamine), Part 2! In part 1 I reviewed proper reporting for Spravato®, including drug administration....

Read More

Coding Conundrum: SPRAVATO® (Eskatamine), Part 1

In 2019, The U.S. Food and Drug Administration approved SPRAVATO® (Eskatamine) nasal spray to be used in conjunction with an oral anti-depressant for...

Read More

Additional Revenue Opportunity Coming in 2024!

Do you remember back in 2021 when CMS first proposed to implement G2211, office/outpatient E/M visit complexity add-on, but the effective date was...

Read More

Evaluation and Management (E/M) Coding Based on Time

In 2021 and 2023, time-based E/M service guidelines underwent significant revisions for office/outpatient and inpatient/observation services. The...

Read More